|1.||Svensson, Anders I: 3 articles (05/2009 - 05/2003)|
|2.||Mørland, Jørg: 2 articles (01/2015 - 06/2006)|
|3.||Hipólide, Débora Cristina: 2 articles (02/2012 - 03/2005)|
|4.||Ameno, Kiyoshi: 2 articles (01/2011 - 07/2008)|
|5.||Kinoshita, Hiroshi: 2 articles (01/2011 - 07/2008)|
|6.||Ricordel, Ivan: 2 articles (11/2008 - 08/2004)|
|7.||Milan, Nathalie: 2 articles (11/2008 - 08/2004)|
|8.||Borron, Stephen W: 2 articles (11/2008 - 07/2005)|
|9.||Megarbane, Bruno: 2 articles (11/2008 - 07/2005)|
|10.||Baud, Frédéric J: 2 articles (11/2008 - 07/2005)|
01/01/1990 - "The treatment cleared the mice of the pinworm infestation, but did not alter the seizure susceptibility or binding parameters of [3H]flunitrazepam in either of the selected lines."
06/26/1998 - "Neither one nor five seizures altered [3H]flunitrazepam binding."
01/01/1995 - "Add-on therapy with flunitrazepam (FNZ) was performed in 5 children with marked sleep disturbance and intractable seizures. "
09/01/1990 - "These data suggest that the decrease in [3H]flunitrazepam binding in stimulated El mice may be due mainly to that of type 1 receptor and may be the result of repeated convulsions."
09/01/1990 - "Specific [3H]flunitrazepam binding in stimulated El mice, which had experienced repeated convulsions, was significantly lower in the cortex and hippocampus than in ddY mice and unstimulated El mice. "
|2.||Sleep Initiation and Maintenance Disorders (Insomnia)
12/18/1980 - "[Study of flunitrazepam in the insomnia of the aged (author's transl)]."
12/18/1980 - "The efficiency of flunitrazepam was evaluated on the three phases of sleep in 20 patients 65 years old and more hospitalized suffering from severe insomnia. "
11/01/1980 - "Although the safe dosage range is wide with flunitrazepam, its effective application both as a hypnotic for insomnia and in anaesthesiology is dependent upon use of the optimal dosage, and adequate knowledge of its pharmacokinetic properties."
10/01/2007 - "Although intravenous midazolam and flunitrazepam are frequently administered for primary insomnia in Japan, there is no empirical study on their efficacy and safety. "
01/01/1995 - "During the early treatment of a major depressive episode with amitryptiline, insomnia was treated in 81 patients in a double-blind comparative trial comparing zopiclone and flunitrazepam. "
10/15/1988 - "Total [3H]Ro5-4864 or [3H]flunitrazepam binding to these sections was indistinguishable from nonspecific binding, and regions of tumor and normal brain could not be delineated. "
07/01/1990 - "Intravenous injection of [3H]flunitrazepam resulted in a tumor/cortex ratio of radioactive densities between 2.7 and 1.5 within the first 60 minutes after injection. "
05/01/1994 - "Clear differences were observed in the competition by both diazepam and flunitrazepam for binding sites in m- and p-fractions from tumors. "
07/01/1990 - "[3H]PK 11195 demonstrated a higher tumor/cortex ratio (5.3) than [3H]flunitrazepam. "
04/01/1994 - "Intracranial pressure, cerebral perfusion pressure, and intracerebral blood volume changes were observed in 43 patients with volumetric intracranial processes (intracranial hematomas, tumors) during general rohypnol anesthesia. "
|4.||Status Epilepticus (Complex Partial Status Epilepticus)
10/01/1989 - "Flunitrazepam (FZP) was administered intravenously, with success, to two patients with status epilepticus. "
10/01/1989 - "Intravenous flunitrazepam for status epilepticus."
01/01/1988 - "Intravenous injection of flunitrazepam for status epilepticus in children--two case reports."
01/01/1988 - "Flunitrazepam might have a potential efficacy for the treatment of status epilepticus of both generalized and partial seizures."
01/01/1988 - "Two cases of status epilepticus are reported, whose seizures responded well to the injection of flunitrazepam. "
03/23/2005 - "Mouse GAT1 (mGAT1) KO mice exhibit motor disorders, including gait abnormality, constant 25-32 Hz tremor, which is aggravated by flunitrazepam, reduced rotarod performance, and reduced locomotor activity in the home cage. "
07/01/1994 - "Furthermore, diazepam and flunitrazepam exhibited a dose-dependent protection against 2,2',2''-tripyridine-induced tremor in mice, but pentobarbital only had a slightly protective effect. "
07/01/1994 - "The inhibitory effects of diazepam and flunitrazepam on the 2,2',2''-tripyridine-induced tremor were potentiated in mice pretreated with p-chlorophenylalanine (PCPA). "
08/21/1987 - "Moreover, tabernanthine-induced tremor was inhibited reversibly by flunitrazepam or by Ro-15 1788 (an antagonist of benzodiazepine-receptors). "
04/01/1995 - "Injection of the specific benzodiazepine receptor antagonist flumazenil (10 mg/kg i.v.) 5 h after the ninth daily oral treatment produced signs of precipitated withdrawal (tremor, vomiting and/or convulsions) in one alprazolam-, four diazepam-, one flunitrazepam- and four oxazepam-treated monkeys, but not in the vehicle-treated monkeys. "
|6.||GABA-A Receptors (GABA(A) Receptor)
|10.||Antidepressive Agents (Antidepressants)
|1.||Drug Therapy (Chemotherapy)